ITMSF
INTERMAP TECHNOLOGIES CORP
$0.7400
+15.63%
No data for this timeframe.
Vol
SEC Reports4
Exchange OTC·Sector Services-Computer Processing & Data Preparation·Inc. A0·CIK 0001285170·Prev Close $0.6400
Recent Activity
Jun 9, 2026
SEC
Intermap Technologies filed its management information circular for the June 24, 2026 annual general meeting. The filing
6-K — Impact 3/10
Jun 1, 2026
SEC
Intermap announced the expansion of its collaboration with Generali Group, deploying its Aquarius RMA platform in Poland
6-K — Impact 6/10
May 13, 2026
SEC
Intermap reported Q1 2026 revenue of $1.4 million, a sharp decline from the prior year, attributed to the timing of larg
6-K — Impact 7/10
Analyst Ratings
1Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 2 bullish, 1 bearish, 0 mixed, 1 neutral. Avg impact: 6.0/10.
NEUTRAL
6-K
3/10
Intermap Technologies filed its management information circular for the June 24, 2026 annual general
Jun 9, 2026
BULLISH
6-K
6/10
Intermap announced the expansion of its collaboration with Generali Group, deploying its Aquarius RM
Jun 1, 2026
BEARISH
6-K
7/10
Intermap reported Q1 2026 revenue of $1.4 million, a sharp decline from the prior year, attributed t
May 13, 2026
BULLISH
6-K
8/10
Intermap reported strong balance sheet growth with $22.5M cash, 29% YoY subscription revenue growth,
Apr 6, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 83% buy across 6 analysts — 1 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 187.9% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 57.4% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 1 | 4 | 1 | 0 | 0 | 83% | |
| May 1, 2026 | 1 | 4 | 1 | 0 | 0 | 83% | |
| Apr 1, 2026 | 1 | 4 | 1 | 0 | 0 | 83% | |
| Mar 1, 2026 | 1 | 4 | 1 | 0 | 0 | 83% | |
| Feb 1, 2026 | 1 | 4 | 1 | 0 | 0 | 83% | |
| Jan 1, 2026 | 1 | 4 | 1 | 0 | 0 | 83% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.